These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 11789025

  • 1. Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3.
    Lewis MR, Boswell CA, Laforest R, Buettner TL, Ye D, Connett JM, Anderson CJ.
    Cancer Biother Radiopharm; 2001 Dec; 16(6):483-94. PubMed ID: 11789025
    [Abstract] [Full Text] [Related]

  • 2. Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2.
    Anderson CJ, Schwarz SW, Connett JM, Cutler PD, Guo LW, Germain CJ, Philpott GW, Zinn KR, Greiner DP, Meares CF.
    J Nucl Med; 1995 May; 36(5):850-8. PubMed ID: 7738663
    [Abstract] [Full Text] [Related]

  • 3. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.
    Rogers BE, Anderson CJ, Connett JM, Guo LW, Edwards WB, Sherman EL, Zinn KR, Welch MJ.
    Bioconjug Chem; 1996 May; 7(4):511-22. PubMed ID: 8853465
    [Abstract] [Full Text] [Related]

  • 4. Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu.
    Connett JM, Anderson CJ, Guo LW, Schwarz SW, Zinn KR, Rogers BE, Siegel BA, Philpott GW, Welch MJ.
    Proc Natl Acad Sci U S A; 1996 Jun 25; 93(13):6814-8. PubMed ID: 8692901
    [Abstract] [Full Text] [Related]

  • 5. Maximum tolerated dose and large tumor radioimmunotherapy studies of 64Cu-labeled monoclonal antibody 1A3 in a colon cancer model.
    Connett JM, Buettner TL, Anderson CJ.
    Clin Cancer Res; 1999 Oct 25; 5(10 Suppl):3207s-3212s. PubMed ID: 10541365
    [Abstract] [Full Text] [Related]

  • 6. Copper-64-labeled antibodies for PET imaging.
    Anderson CJ, Connett JM, Schwarz SW, Rocque PA, Guo LW, Philpott GW, Zinn KR, Meares CF, Welch MJ.
    J Nucl Med; 1992 Sep 25; 33(9):1685-91. PubMed ID: 1517844
    [Abstract] [Full Text] [Related]

  • 7. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR, Wang M, Axworthy DB, Theodore LJ, Mallet RW, Fritzberg AR, Welch MJ, Anderson CJ.
    J Nucl Med; 2003 Aug 25; 44(8):1284-92. PubMed ID: 12902420
    [Abstract] [Full Text] [Related]

  • 8. 67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.
    DeNardo GL, Kukis DL, Shen S, DeNardo DA, Meares CF, DeNardo SJ.
    Clin Cancer Res; 1999 Mar 25; 5(3):533-41. PubMed ID: 10100704
    [Abstract] [Full Text] [Related]

  • 9. Antibody responses to macrocycles in lymphoma.
    DeNardo GL, Mirick GR, Kroger LA, O'Donnell RT, Meares CF, DeNardo SJ.
    J Nucl Med; 1996 Mar 25; 37(3):451-6. PubMed ID: 8772643
    [Abstract] [Full Text] [Related]

  • 10. Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma.
    DeNardo GL, DeNardo SJ, O'Donnell RT, Kroger LA, Kukis DL, Meares CF, Goldstein DS, Shen S.
    Clin Lymphoma; 2000 Sep 25; 1(2):118-26. PubMed ID: 11707820
    [Abstract] [Full Text] [Related]

  • 11. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct 25; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

  • 12. Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.
    Kukis DL, DeNardo GL, DeNardo SJ, Mirick GR, Miers LA, Greiner DP, Meares CF.
    Cancer Res; 1995 Feb 15; 55(4):878-84. PubMed ID: 7850803
    [Abstract] [Full Text] [Related]

  • 13. Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.
    Denardo GL, Denardo SJ, Kukis DL, O'Donnell RT, Shen S, Goldstein DS, Kroger LA, Salako Q, Denardo DA, Mirick GR, Mausner LF, Srivastava SC, Meares CF.
    Anticancer Res; 1998 Feb 15; 18(4B):2779-88. PubMed ID: 9713461
    [Abstract] [Full Text] [Related]

  • 14. Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients.
    Mirick GR, O'Donnell RT, DeNardo SJ, Shen S, Meares CF, DeNardo GL.
    Nucl Med Biol; 1999 Oct 15; 26(7):841-5. PubMed ID: 10628566
    [Abstract] [Full Text] [Related]

  • 15. Biodistribution and histological localization of anti-human colon cancer monoclonal antibody (MAb) 1A3: the influence of administered MAb dose on tumor uptake.
    Fenwick JR, Philpott GW, Connett JM.
    Int J Cancer; 1989 Dec 15; 44(6):1017-27. PubMed ID: 2691405
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a direct method for technetium labeling intact and F(ab')2 1A3, an anticolorectal monoclonal antibody.
    Schwarz SW, Connett JM, Anderson CJ, Rocque PA, Philpott GW, Guo LW, Welch MJ.
    Nucl Med Biol; 1994 May 15; 21(4):619-26. PubMed ID: 9234319
    [Abstract] [Full Text] [Related]

  • 17. Comparative uptakes and biodistributions of internalizing vs. noninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer.
    Bryan JN, Jia F, Mohsin H, Sivaguru G, Miller WH, Anderson CJ, Henry CJ, Lewis MR.
    Nucl Med Biol; 2005 Nov 15; 32(8):851-8. PubMed ID: 16253810
    [Abstract] [Full Text] [Related]

  • 18. 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation.
    Rossin R, Pan D, Qi K, Turner JL, Sun X, Wooley KL, Welch MJ.
    J Nucl Med; 2005 Jul 15; 46(7):1210-8. PubMed ID: 16000291
    [Abstract] [Full Text] [Related]

  • 19. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.
    Sprague JE, Peng Y, Sun X, Weisman GR, Wong EH, Achilefu S, Anderson CJ.
    Clin Cancer Res; 2004 Dec 15; 10(24):8674-82. PubMed ID: 15623652
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
    Cai W, Wu Y, Chen K, Cao Q, Tice DA, Chen X.
    Cancer Res; 2006 Oct 01; 66(19):9673-81. PubMed ID: 17018625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.